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1st Editorial Decision 22 August 2012 
Thank you for having submitted a manuscript entitled "The functional interactome landscape of the 
human histone deacetylase family" for consideration for publication in Molecular Systems Biology.  
Your paper has now been seen by Editors of the Journal, and we have decided to return it to you 
without sending it for extensive peer review.  
 
In this study, you use affinity purification and mass spectrometry to identify binding partners for all 
eleven human HDAC proteins. Purifications are performed from CEM-T cells expressing tagged 
HDAC proteins, and the mass spectrometry analysis includes multiple replicates, rigorous statistical 
analysis of binding specificity, and additional I-DIRT experiments to help identify fast-exchanging 
interactors. Some of these interactors are confirmed with additional immunoprecipitation and 
colocalization experiments. These interactions further support connections between HDACs and cell 
cycle components, and allow you to propose some new functional associations for the different 
HDACs. We acknowledge that this work provides a detailed dataset of HDAC interactors, and 
suggests functional differences that may deserve further investigation. At this time, however, we 
feel that the novel conceptual insights into HDAC protein function remain somewhat modest. 
Moreover, the mechanistic relevance the most novel interactions for HDAC function, or the ability 
of these results to advance our understanding of HDACs in human disease, remains somewhat 
unclear, especially in the absence of more in depth investigation. Overall, we are not convinced that 
the present study provides the degree of novel biological insight and conclusiveness our audience 
would expect in Molecular Systems Biology.  
 
I am very sorry to have to disappoint you on this occasion, but I hope that this early decision will 
allow you to submit your work elsewhere without undue delay.  
 
 Re-submission 30 January 2013 
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January 30, 2013 
 
We are submitting our revised manuscript entitled “The functional interactome landscape of the 
human histone deacetylase family,” for publication as an Article in Molecular Systems Biology. Please 
note that this is a revised manuscript of our original submission (MSB-12-3981). We consider Molecular 
Systems Biology to be the ideal journal for this significant and large-scale study, and therefore, have 
opted to perform additional experiments and address all the concerns raised by the editor and resubmit 
it, rather than submitting it to other journals. In the description below, we highlight the Novelty, 
Methodology Development, Functional Assays and Insight, and Impact of our study. Sorry for the long 
message; we just tried to thoroughly address the issues raised by the previous evaluation. 
 
This manuscript is the results of an extensive study, which my lab has been pursuing over the course of 
five years, presenting the first global protein interactome for all eleven human histone deacetylases 
(HDAC1-HDAC11). The significance and novelty of our results is further enhanced by the 
performance of these studies in T cells (see below). Histone deacetylases are essential transcriptional 
regulators, critically linked to cancer, immune, infectious and cardiac disease. Given their impact on 
human disease, selected HDACs have been the subject of intense study and are targets for anti-cancer 
therapy. However, the interactions and functions of many HDACs are not yet fully understood; this 
knowledge is required for understanding their contribution to different cellular pathways and the future 
design of therapeutics targeting sub-complexes. The significant findings and novelty of our manuscript 
are: 
 
GENERAL NOVELTY: 
1) We report the first global protein interactome for all eleven human histone deacetylases (HDAC1-
HDAC11).  
 
2) This is the first proteomic study for any histone deacetylase in T cells. A large fraction of the current 
knowledge of interactions comes from studies of individual HDACs performed in common lab cell 
lines (e.g., HeLa cells). T cell biology critically depends on HDACs for regulating cellular and 
developmental processes, such as apoptosis, differentiation, and immune response. T cells 
have important clinical relevance, as small molecules that inhibit HDACs are used for treatment of 
cutaneous T-cell lymphomas (CTCL). Yet, the presence of off-target effects or development of 
resistance are key issues. This requires the discovery of more selective targets, such as unique HDAC 
sub-complexes. To achieve this level of selectivity, we require a better understanding of the ensemble of 
common and distinct HDAC interactions and their functions as related to T cell biology. Our study fills 
a significant gap in knowledge of HDAC interactions in T cells.  
 
NOVEL METHODOLOGY: 
3) We designed a hybrid approach integrating label-free and isotope-labeling quantification to profile 
relative interaction stability across co-isolated protein complexes. The ability of this approach to 
distinguish stable from fast-exchanging HDAC interactions is shown in the new Figure 6. We 
demonstrated class- and function-dependent differences in relative interaction stability of several 
HDACs. We define previously unreported stable HDAC interactions, and globally demonstrate that 
well-established chromatin remodeling HDAC1 interactions are largely stable within their complexes, 
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while transcription factors preferentially exist in rapid equilibrium. This hybrid approach is not 
restricted to HDAC interactions but would be suited to profile interaction stability for many different 
complexes. 
 
4) Our study also provides methodological novelty for assessing specificity of protein interactions. We 
have improved the performance of the label-free-based SAINT algorithm for dealing with 
heterogeneous datasets with a large dynamic range of protein abundance.  
 
5) By integrating fluorescence microscopy, rapid immunoaffinity purifications (optimized for each 
HDAC), quantitative mass spectrometry, bioinformatics clustering, functional network analysis, and 
improved bioinformatics tools for assessing interaction specificity, we identify specific interaction 
patterns for each HDAC and define common and distinct features of HDAC interactions in T cells. 
The combination of these orthogonal approaches allowed us to define specific HDAC interactions at 
high confidence, as demonstrated by the high rate of successful validation and functional relevance of 
our interactions. 
 
NOVEL FUNCTIONAL ELUCIDATION: 
6) To date, HDAC11 remains the least characterized histone deacetylase, with very few reports 
describing its interactions (<10 interactions in BioGRID) or biological functions.  In our study, we 
demonstrate that HDAC11 is a member of the survival of motor neurons (SMN) complex. The SMN 
complex interacts with snRNPs and, importantly, contains the disease gene product SMN responsible 
for the neurodegenerative disorder, spinal muscular atrophy. Next, we performed functional analyses, 
and showed that HDAC11 down-regulation in T cells triggers a functional U12-type splicing defect, 
resulting in the accumulation of mis-spliced ATXN10 mRNA. These results do not only provide the 
first interactome for HDAC11 and its functional association with the SMN complex, but also establish 
for the first time that HDAC11 is involved in mRNA splicing (new Figure 5).  
 
7) HDACs are known to depend on protein interactions to exert their functions. However, the 
interactions of the majority of these enzymes (HDAC6, 8, 9, 10 and 11) remain poorly characterized. 
An integrative view of HDAC interactions also lacks for some of the better understood enzymes. 
Emerging evidence shows that there are still critical protein interactions to be identified. One example 
is our identification of specific interactions of HDAC1 with FAM60A and HDAC8 with SMC3. 
Following the first submission of our manuscript to MSB, a high-profile study (Deardorff MA, Nature 
2012) showed that knockdown of HDAC8 triggers an increase in SMC3 acetylation, and that loss-of-
function HDAC8 mutations impaired cohesin complex regulation, being linked to the congenital 
malformation disorder, Cornelia de Lange syndrome. Our study demonstrates the association of 
HDAC8 with SMC3, as well as other members of the cohesion complex in T Cells. Similarly, during the 
preparation of this manuscript, FAM60A was reported to be a member of the HDAC1-Sin3 complex, 
responsible for the recruitment of the complex to cyclin D1. These examples further emphasize the 
significance of our manuscript for discovering novel interactions critical for diverse HDAC functions. 
In addition to confirming previously reported interactions, our study identified over 200 novel, specific 
interactions for HDACs 1-11. Interestingly, a subset of these interactions provides important support 
for the emerging functional relationship between deacetylation and demethylation. We determine for 
the first time that the lysine demethylase KDM1A and the DNA-binding transcription co-factor 
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RREB1 exist as part of an HDAC3-containing sub-complex, possibly representing a novel corepressor 
complex.  
 
Collectively, our work has generated the first global interaction dataset for the eleven human histone 
deacetylases. The use of global proteomics and targeted functional studies have provided a valuable 
resource of global HDAC interactions, encompassing the composition and stability of HDAC 
complexes, insights into less well-characterized HDACs, and targets for investigating HDAC functions 
in health and disease states. We expect that this study will generate a lot of interest in the scientific 
community and will be cited accordingly. I am confident that our work fits the high standard and broad 
readership of Molecular Systems Biology.  
 
Thank you for your time and consideration! 
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2nd Editorial Decision 07 March 2013 
Thank you again for submitting your work to Molecular Systems Biology. We have now heard back 
from the three referees who agreed to evaluate your manuscript. As you will see from the reports 
below, the referees find the topic of your study of potential interest. They raise, however, substantial 
concerns on your work, which should be convincingly addressed in a revision of the manuscript.  
 
One of the major points that should be carefully addressed refers to the need to validate the results 
obtained using the I-DIRT method. Reviewers #1 and #3 include constructive suggestions in this 
regard.  
 
On a more editorial level, I would kindly ask you to deposit the MS datasets and molecular 
interaction data in the appropriate public databases. (Additional information is available in the 
"Guide for Authors" section in our website at 
<http://www.nature.com/msb/authors/index.html#a3.5.2>) Furthermore, I would like to ask you to 
include the links and accession numbers in the "Data Availability" section of your manuscript.  
 
If you feel you can satisfactorily deal with these points and those listed by the referees, you may 
wish to submit a revised version of your manuscript. Please attach a covering letter giving details of 
the way in which you have handled each of the points raised by the referees. A revised manuscript 
will be once again subject to review and you probably understand that we can give you no guarantee 
at this stage that the eventual outcome will be favorable.  
 
REFEREE REPORTS: 
--------------------------------------------------------  
 
Reviewer #1 (Remarks to the Author):  
 
This manuscript describes the human histone deactylase protein interaction network in T-cells. The 
authors analyzed the interactions of all 11 human HDACs using state of the art proteomics 
approaches and the SAINT protein interaction network analysis approach. The authors use imaging 
and western blotting to validate approaches and particular strengths are the analysis of the poorly 
characterized HDAC11 protein associations and possibly the interaction stability by combining 
SAINT and I_Dirt ratios. The body of work will be of interest to a wide research community but the 
manuscript is in need of major revisions at this time.  
 
The first major concern is the tag itself skewing the results dramatically. The control imaging 
experiment in Figure 1 appears to demonstrate that EGFP alone is targeted to the nucleus. All of the 
HDACs appear to be targeted to the nucleus, albeit with different levels of intensity. HDAC4 and 
HDAC5 appear to have some cytoplasmic localization, for example, but they still are predominantly 
nuclear. If this tag itself is forcing a skewed localization of all the HDACs to localization the 
interaction network results would be skewed also and a major effort would be needed to correct for 
this. All the data in Figure 7 is also largely nuclear. The authors need to explain this carefully in the 
manuscript since I may be misinterpreting the EGFP results, but the data presented clearly overlaps 
with DAPI staining. Providing supplemental images where a few proteins with and EGFP tag that 
should not be in the nucleus do not go into the nucleus would help alleviate this concern.  
 
Another concern is the interpretation and justification of the interaction stability generated from the 
SAINT score and I-Dirt combination. This is an intriguing possibility and would be valuable if true. 
Currently it is an interesting observation, but I am not convinced of the argument. The authors 
should develop in vitro biochemical experiments or perhaps imaging based experiments to show fast 
and slow exchange of interactions. Validation of this data with a non-proteomic approach would go 
a long way to supporting this intriguing potential claim.  
 
In the discussion, the manuscript would benefit from framing the presentation of the data with 
respect to T-cell biology. In reality, this is not a general human HDAC protein interaction network it 
is the T-cell HDAC protein interaction network. This is a good opportunity for the authors to stress a 
strength of the study, which is the work was not done in HeLA or HEK293 cells.  
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One minor concern, but still needs addressing is it is not clear why HDAC11 was excluded from the 
interaction network. This section needs to be rewritten with a mathematical, for example, 
justification given for HDAC11 exclusion.  
 
Reviewer #2 (Remarks to the Author):  
 
In this manuscript, Joshi and collaborators report an interaction network including all human 
HDACs in T-cells. The integrated affinity purification (single GFP immuno-affinity step) and 
quantitative mass spectrometry to characterize the sets of proteins interacting with 11 human 
HDACs. The experimental strategy is standard and state-of-the-art (AP/MS). The data analysis is 
also based on well established strategies (SAINT and integration of STRING data). The experiments 
are very well controlled and carefully done. This implies an in depth characterization of the baits 
(EGFP-fusion) in terms of localization and HDAC activity. The authors could demonstrate that the 
C-terminally EGFP-tagged HDACs are enzymatically active and localize similarly to the wild type 
versions. The data look solid and imply over 200 previously unreported HDAC interactions. The 
authors provide further evidence (co-IP and functional assay) for a role of HDAC11 in mRNA 
splicing. The dataset is likely to be of interest to the scientific community and deserves publication. 
Several important points though should be addressed:  
1) Adaptation of the SAINT algorithm to the HDAC interactome. The cut-off used, i.e. 0.75, 0,9 and 
0.95 depending on the HDAC considered (and the numbers of prey found) seems a bit arbitrary. In 
agreement with this, the authors needed to add back manually MEF2C, a well known HDAC 
interactors that was filtered out by the procedure. Could it be that too stringent cut-offs have been 
applied and other real interactors were filtered out? The authors should produce a ROC curve that 
should easily address the point.  
2) Phylogenetic relationships among different HDACs (Figures 3). This part is confusing, as the text 
does not relate to what is being shown in Figures 3. The authors say "This is consistent with 
HDAC1 and HDAC2 comprising a catalytic core that functions as part of several multi-protein 
complexes, including NuRD and CoREST." Is this literature? Then a reference should be provided. 
Is this results? Then this should be shown in figure 3.  
Similarly, "Three class IIa members, HDAC4, 5, and 7, were part of a single cluster, while HDAC9 
had a prey protein profile most similar to HDAC8. For this class, clustering was driven by shared 
interactions with the nuclear co-repressor complex (NCoR) (Figure 3, orange) and the 14-3-3 
proteins (Figure 3, purple), which facilitate nucleo-cytoplasmic shuttling of class IIa HDACs 
(Grozinger & Schreiber, 2000; Kao et al, 2001; McKinsey et al, 2000b; Yang & Gregoire, 2005)." 
This is completely unclear. First HDAC8 and 9 do not (apparently) co-cluster in Figure 3 and 
second, neither NCoR nor 14-3-3 can be seen.  
More worrisome the authors then, a few sentence later, claim that HDAC6, HDAC8 and HDAC9 
are "not part of larger clusters, each forming their own distinct gene cluster (Figure 3, yellow, teal, 
and blue)". This is apparently contradictory to their statement above.  
3) Analysis of the HDAC11 interactome. The figure S2 and the STRING analysis should be 
clarified, indeed how can they find that NUP153 and Dicer1 interact when none of these proteins 
have been used as bait. I guess this is not experimental, but STRING data. Then one wonders what 
the relevance of this interaction/observation here is. Indeed, they (apparently) did not observe the 
interaction between NUP153 and Dicer, but it was known before. Also in Figure S2 (and 5c) 
HDAC11 cannot be seen, but these proteins are HDAC11 interactors, this needs clarification.  
4) Dynamics of HDAC protein interaction using I-DIRT. It would be interesting to discuss the 
possible impact of bait-prey stoichiometries on the apparent exchange of differentially labeled prey.  
 
Reviewer #3 (Remarks to the Author):  
 
Review of "The functional interactome landscape of the human histone deacetylase family."  
 
In this paper, the authors identify the cellular proteins that interact with histone deacetylase (HDAC) 
proteins in human T cells. Interactome datasets were compiled for each of the 11 HDACs via label-
free affinity purification followed by MS-MS, and then SAINT analysis. Over 200 novel 
interactions were identified and HDAC-centric interactomes revealed HDAC involvement in a 
variety of processes including ubiquitination and cell cycle regulation. Independent analysis of 
HDAC11 revealed association with RNA editing and processing, specifically with the SMN 
subnetwork. Downregulation of HDAC11 was associated with accumulation of splicing defects in 
ATXN10 gene. The authors complemented their finding with a metabolic labeling approach, I-
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DIRT, to assess the relative stability of interactions and the binding characteristics of each of the 
HDACs.  
 
This paper is very impactful in that it provides the first comprehensive and global interactome for 
HDAC proteins. We agree with the authors that this is particularly important given that HDACs are 
the targets of several drugs in clinical trials, but the ability to assess their global effect is impaired 
due to lack of knowledge about the biological pathways and systems in which HDACs are involved. 
Additionally, the authors have developed a hybrid proteomic approach that can be adapted to the 
study of other protein interaction networks. By using numerous examples from the literature, they 
show that the complementarity of the two approaches raises the confidence level of the interactions 
identified. Overall the paper is well researched, contains a high degree of novelty and is a useful 
resource platform for further investigations into the HDAC protein family.  
 
Major comments  
The authors should find a way to validate the I-DIRT method. They show binding by two proteins 
by IP and by colocalization, but they do not show a way to validate their binding strength. This can 
be done, for example, by salt extraction.  
 
In the HDAC11 analysis only one intron of the ATXN10 gene is shown to be misspliced while the 
wording of the relevant section claims that SMN1 deletion purturbs the splicing of more than one 
U12 intron (Boulisfane et al, 2011). Did the authors check any of the other introns? If there wasn't 
intron retention, was there a difference in splicing efficiency? Can the authors check some other 
genes with U12 introns to show that this is a general phenomenon?  
 
Minor comments:  
In section "Protein interaction clustering reflect phylogenetic relationships and functional 
commonalities among distinct HDACs": The authors write "HDAC bait spectral counts were 
removed to prevent clustering bias", but the heatmap figure contains HDAC proteins and spectral 
counts even in the vector representing the experiment in which they should be the bait (e.g. HDAC1 
has a yellow color in columns one and two representing the HDAC 1-1 and HDAC1-2 affinity 
assays). This should be clarified.  
 
- Can the authors explain why the interactome and heatmap don't contain histone proteins? The 
interaction table in the Excel file contains histone proteins for several of the HDACs but they are not 
shown in the heatmap.  
 
- "Clustering of biological replicates showed highest similarity to each other" - this is not so for 
HDAC5-1, HDAC5-2, or HDAC4-3. This sentence should be less absolute. Also, why do some 
HDACs have three biorepeats? Should be clarified.  
 
In wording referring to Figure 6, the gene HBP1 (Swanson et al, 2004) is mentioned, but it is not in 
the figure.  
 
The reference to Figure S4 should be S3.  
 
In Figure 5B, the meaning of the clump of green circles at the bottom is unclear.  
 
In Figure 6C,D the Y axis is named differently. In C it's "SAINT score" and in D it's "SAINT 
probability". For D, the graph is unnecessary since it contains no points. It's enough to have the 
color bar with a number legend for the I-DIRT stability ratio and then the chart on the right of the 
HDACs vs. other proteins.  
 
Figure 2A - where does the metabolic -labeled affinity purification come in to play? The box says 
LC-MS/MS Analysis...  
 
 
 
1st Revision - authors' response 09 April 2013 
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April 9, 2013 
 
 
We appreciate the valuable insight and positive comments of the reviewers, and have revised our manuscript to include 
all suggested changes. We have performed all suggested experiments and have included 6 new figures, one as a new 
Figure 7 and 5 new supplementary figures (Figs. S1, S3, S4, S6, and S7). Importantly, as requested by you and the 
reviewers, we have provided experimental validation of the I-DIRT results, demonstrating that this is a new approach 
for assessing relative protein interaction stability. Overall, we have addressed all raised concerns, and as a result the 
manuscript is significantly improved and suitable for publication in Molecular Systems Biology journal. We provide the 
point-by-point description of the changes we have made in response to the reviewer’s specific suggestions at the end of 
this file. Additionally, as requested, the mass spectrometry proteomics data and molecular interactions have been 
deposited to ProteomeXchange Consortium (PXD000208) and IntAct (IM-18733), respectively. 
 
As a reminder of the topic and main findings that our manuscript presents, this manuscript is the result of an extensive 
study, presenting the first global protein interactome for all eleven human histone deacetylases (HDAC1-HDAC11). As 
recognized by the reviewers, the significance of our results is further enhanced by the performance of these studies in 
human T cells. Histone deacetylases are essential transcriptional regulators, critically linked to cancer, immune, 
infectious and cardiac disease. Given their impact on human disease, selected HDACs have been the subject of intense 
study and are targets for anti-cancer therapy. However, the interactions and functions of many HDACs are not yet fully 
understood; this knowledge is required for understanding their contribution to different cellular pathways and the future 
design of therapeutics targeting sub-complexes. The significant findings and novelty of our manuscript are: 
 
GENERAL NOVELTY: 
1) We report the first global protein interactome for all eleven human histone deacetylases (HDAC1-HDAC11).  
 
2) This is the first proteomic study for any histone deacetylase in T cells. A large fraction of the current knowledge of 
interactions comes from studies of individual HDACs performed in common lab cell lines (e.g., HeLa cells). T cells 
have important clinical relevance, as small molecules that inhibit HDACs are used for treatment of cutaneous T-cell 
lymphomas (CTCL). Yet, the presence of off-target effects or resistance are key issues. This requires the discovery of 
more selective targets, such as unique HDAC sub-complexes. Our study fills a significant gap in knowledge of HDAC 
interactions in T cells.  
 
NOVEL METHODOLOGY: 
3) We designed a hybrid approach integrating label-free and isotope-labeling quantification to profile relative 
interaction stability across co-isolated protein complexes. This approach is not restricted to HDAC interactions, and 
would be suited to profile interaction stability for many different complexes. 
 
4) Our study also provides methodological novelty for assessing specificity of protein interactions. We have improved 
the performance of the label-free-based SAINT algorithm for dealing with heterogeneous datasets with a large dynamic 
range of protein abundance.  
 
5) By integrating fluorescence microscopy, immunoaffinity purifications, quantitative mass spectrometry, 
bioinformatics clustering, functional network analysis, biochemistry approaches, and improved bioinformatics tools, we 
identified specific interaction patterns for each HDAC and defined common and distinct features of HDAC interactions 
in T cells.  
 
NOVEL FUNCTIONAL ELUCIDATION: 
6) To date, HDAC11 remains the least characterized histone deacetylase, with very few reports describing its 
interactions (<10 interactions in BioGRID) or biological functions.  In our study, we demonstrate that HDAC11 is a 
member of the survival of motor neurons (SMN) complex. The SMN complex interacts with snRNPs and, importantly, 
contains the disease gene product SMN responsible for the neurodegenerative disorder, spinal muscular atrophy. We 
performed functional analyses and showed that HDAC11 down-regulation in T cells triggers a functional U12-type 
splicing defect, resulting in the accumulation of mis-spliced ATXN10 mRNA. These results provide the first 
interactome for HDAC11, revealing a functional association with the SMN complex and establishing for the first time 
that HDAC11 is involved in mRNA splicing.  
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7) HDACs are known to depend on protein interactions to exert their functions. However, the interactions of the 
majority of these enzymes (HDAC6, 8, 9, 10 and 11) remain poorly characterized. An integrative view of HDAC 
interactions also lacks for some of the better understood enzymes. Emerging evidence shows that there are still critical 
protein interactions to be identified. One example is our identification of specific HDAC8-SMC3 interaction. Following 
the first submission of our manuscript to MSB, a high-profile study (Deardorff MA, Nature 2012) showed that 
knockdown of HDAC8 triggers an increase in SMC3 acetylation, and that loss-of-function HDAC8 mutations impaired 
cohesin complex regulation, being linked to the congenital malformation disorder, Cornelia de Lange syndrome. Our 
study demonstrates the association of HDAC8 with SMC3 and other members of the cohesion complex in T Cells. This 
example further emphasize the significance of our manuscript for discovering novel interactions critical for diverse 
HDAC functions. In addition to confirming previously reported interactions, our study identified over 200 novel, 
specific interactions for HDACs 1-11. Interestingly, a subset of these interactions provides important support for the 
emerging functional relationship between deacetylation and demethylation.  
 
Collectively, our work has generated the first global interaction dataset for the eleven human histone deacetylases. The 
use of global proteomics and targeted functional studies have provided a valuable resource of global HDAC 
interactions, encompassing the composition and stability of HDAC complexes, insights into less well-characterized 
HDACs, and targets for investigating HDAC functions in health and disease states. We expect that this study will 
generate a lot of interest in the scientific community and will be cited accordingly. I am confident that our work fits the 
high standard and broad readership of Molecular Systems Biology.  
 
Thank you for your time and consideration! 
 
Sincerely, 
Ileana Cristea (Princeton U.) & Alexey Nesvizhskii (U. Michigan) 
Point-by-point response to reviewers: 
 
Thank you for your careful consideration of our manuscript number MSB-13-4361, entitled “The functional interactome 
landscape of the human histone deacetylase family”. We appreciate the valuable insight and positive comments of the 
reviewers, and have revised our manuscript to include all suggested changes. We have performed all suggested 
experiments and have included 6 new figures, one as a new Figure 7 and 5 new supplementary figures (Figs. S1, S3, S4, 
S6, and S7). Overall, we have addressed all raised concerns, and as a result the manuscript is significantly improved and 
suitable for publication in Molecular Systems Biology journal. Below is provided a point-by-point description of the 
changes we have made in response to the reviewer’s specific suggestions. Page numbers in our responses refer to the 
revised manuscript; reviewer’s comments are marked with “>” and our responses are shown in italics. Thank you again 
for your time. 
 
Reviewer #1 (Remarks to the Author):  
 
This manuscript describes the human histone deactylase protein interaction network in T-cells. The authors analyzed the 
interactions of all 11 human HDACs using state of the art proteomics approaches and the SAINT protein interaction 
network analysis approach. The authors use imaging and western blotting to validate approaches and particular 
strengths are the analysis of the poorly characterized HDAC11 protein associations and possibly the interaction stability 
by combining SAINT and I_Dirt ratios. The body of work will be of interest to a wide research community but the 
manuscript is in need of major revisions at this time.  
 
>The first major concern is the tag itself skewing the results dramatically. The control imaging experiment in Figure 1 
appears to demonstrate that EGFP alone is targeted to the nucleus. All of the HDACs appear to be targeted to the 
nucleus, albeit with different levels of intensity. HDAC4 and HDAC5 appear to have some cytoplasmic localization, for 
example, but they still are predominantly nuclear. If this tag itself is forcing a skewed localization of all the HDACs to 
localization the interaction network results would be skewed also and a major effort would be needed to correct for this. 
All the data in Figure 7 is also largely nuclear. The authors need to explain this carefully in the manuscript since I may 
be misinterpreting the EGFP results, but the data presented clearly overlaps with DAPI staining. Providing 
supplemental images where a few proteins with and EGFP tag that should not be in the nucleus do not go into the 
nucleus would help alleviate this concern.  
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The localization of a tagged protein is an important aspect on which we have focused significant attention and have 
carefully assessed in our initial studies of HDACs. We have experience with functionally assessing protein tagging, 
and have established that the EGFP tag does not lead to an increased nuclear localization. We present several lines 
of evidence for this within our HDAC study (shown in Figure 1 and new Figure S1): 1) the sole cytoplasmic 
localization of HDAC6-EGFP, 2) the dual nuclear and cytoplasmic localizations of class IIa HDACs, 3) dual 
localization of HDAC10 and HDAC11, and 4) the pan-cellular localization of the EGFP control cell line. To clarify 
these observations, as suggested by the reviewer, we have included supplementary figures that clearly demonstrate 
the cytoplasmic and pan-cellular localizations mentioned above (new Fig. S1). Additionally, it is noteworthy to 
emphasize that these studies are performed in T cells. CEM T-cells are suspension cells, in which the nucleus 
occupies the majority of the cell volume, and the cytoplasm is present as a relatively thin layer around the nucleus.  
 
We have added this new information and discussion on pages 7-8: 
“To confirm that the EGFP tag does not interfere with subcellular localization, we examined each tagged HDAC by 
immunofluorescence microscopy. Expression of the EGFP tag alone demonstrates that EGFP displays a diffuse 
localization to both the nucleus and the cytoplasm in CEM T-cells (Figure 1 and S1A), similar to our previous 
observations in EGFP HEK293 cell lines (Figure S1A). Class I HDACs have been reported to localize to the nucleus, 
which was mimicked in our observations of EGFP-tagged HDAC localizations. Class IIa enzymes are known to shuttle 
between the nucleus and the cytoplasm, allowing these HDACs to interact with both nuclear and cytoplasmic proteins 
in a localization-dependent manner (Greco et al, 2011; Grozinger & Schreiber, 2000; McKinsey et al, 2000a; Paroni et 
al, 2007; Zhao et al, 2001). Consistent with their known shuttling ability, the EGFP-tagged HDAC4, 5, 7, and 9 were 
distributed to both nuclear and cytoplasmic compartments, with HDAC4 showing increased cytoplasmic localization 
when compared to the remaining class IIa HDACs, which were instead predominately nuclear and only partially 
cytoplasmic. A similar dual localization phenotype was observed for the class IIb enzyme HDAC10, while HDAC6 was 
predominately cytoplasmic (Figure 1), consistent with previous reports of HDAC6 as a cytoplasmic deacetylase 
(Hubbert et al, 2002). While the morphology of CEM T-cells grown in suspension provides a minor challenge in 
visualizing cytoplasmic proteins, as the nucleus occupies a substantial fraction of the total cell volume, close 
examination illustrates the HDAC6 cytoplasmic enrichment and the dual localizations detailed above (Figure S1B). 
Therefore, while HDAC localizations have not previously been fully characterized in T-cells, our results agree with 
endogenous protein localizations reported for HDACs in various cell types (Keedy et al, 2009; Yang & Seto, 2008).” 
 
 
>Another concern is the interpretation and justification of the interaction stability generated from the SAINT score and 
I-Dirt combination. This is an intriguing possibility and would be valuable if true. Currently it is an interesting 
observation, but I am not convinced of the argument. The authors should develop in vitro biochemical experiments or 
perhaps imaging based experiments to show fast and slow exchange of interactions. Validation of this data with a non-
proteomic approach would go a long way to supporting this intriguing potential claim.  
 
We agree with the reviewer that the use of the integrated I-DIRT/SAINT approach for determining relative 
interaction stability is very valuable and can be utilized when studying diverse complexes, and that these findings 
could be strengthened by additional experiments. To validate our I-DIRT observations, we have designed and 
successfully performed two experiments: 
1. We performed a biochemical validation of HDAC1 interaction stability. We isolated HDAC1-EGFP using 
lysis buffer conditions with increasing salt concentrations. To determine the relative resistance of the 
interactions to the increased salt concentrations, we analyzed the co-isolated proteins by mass spectrometry. 
Stable interactions, such as the NuRD complex, remained largely associated with HDAC1 at high salt 
concentration. In contrast, the interactions with transcription factors and zinc finger proteins were depleted 
in a dose-dependent manner. A clear validation of our I-DIRT results is given by the striking difference 
between the trends of the zinc finger proteins. The known CtBP complex components, ZNF516 and 
ZNF217, were stable at high salt concentrations, while the previously uncharacterized zinc finger proteins 
that I-DIRT predicted as less stable interactions were depleted in a KCl-dependent manner. We illustrate 
these results in the new Figure 7A.  
2. Similarly, we performed additional validation of HDAC7 interaction stability with TBL1XR1 and HDAC3. 
I-DIRT predicted these interactions as less stable, in agreement with the nuclear-cytoplasmic shuttling of 
HDAC7. Upon isolation of HDAC7-EGFP under lysis buffer conditions with increasing KCl 
concentrations, we demonstrate by Western blotting that these HDAC7 interactions are diminished in a 
dose-dependent manner. We illustrate these results in the new Figure 7B. 
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We have included these new Results on pg 21-22: 
“To biochemically validate the ability of the I-DIRT/SAINT approach to determine relative interaction stability, we 
independently isolated HDAC1-EGFP using lysis buffer conditions with increasing KCl concentrations. We 
assessed the relative abundance of co-isolated interactions by mass spectrometry. As predicted, stable interactions, 
such as the NuRD complex, remained largely associated with HDAC1 at high salt concentration (Figure 7A). In 
contrast, the interactions with transcription factors and zinc finger proteins were depleted in a dose-dependent 
manner. A clear validation of our I-DIRT results is shown by the striking difference between the relative stability 
trends of zinc finger proteins. The known CtBP complex components, ZNF516 and ZNF217, were stable at high 
salt concentrations, while the previously uncharacterized zinc finger proteins that I-DIRT predicted as less stable 
interactions (Figure 6E-F) were depleted in a KCl-dependent manner (Figure 7A). Similarly, we performed 
validation of HDAC7 interaction stability with TBL1XR1 and HDAC3 (Figure 7B). I-DIRT predicted these 
interactions as less stable (Figure 6B), in agreement with the nuclear-cytoplasmic shuttling of HDAC7. Upon 
isolation of HDAC7-EGFP under lysis buffer conditions with increasing KCl concentrations, we observed by 
Western blotting that TBL1XR1 and HDAC3 are diminished in a dose-dependent manner. Altogether, these results 
support the use of the integrated I-DIRT/SAINT approach for profiling relative protein interaction stabilities.” 
 
 
>In the discussion, the manuscript would benefit from framing the presentation of the data with respect to T-cell 
biology. In reality, this is not a general human HDAC protein interaction network it is the T-cell HDAC protein 
interaction network. This is a good opportunity for the authors to stress a strength of the study, which is the work was 
not done in HeLA or HEK293 cells.  
 
We thank the reviewer for pointing this out, as we believe that carrying out these experiments in T cells brings an 
important additional significance to the study. As the reviewer suggested, we have now added discussion to 
emphasize this aspect (pg. 24-25).  
“This interactome network was assembled from protein-protein interactions in human CEM T-cells. Eleven CEM T-cell 
lines were independently constructed, with stable expression, localization, and activity confirmed for each EGFP-
tagged HDAC. To our knowledge, this is the first proteomic study for any histone deacetylase in T-cells. A large 
fraction of the current knowledge of interactions comes from studies of individual HDACs performed in common lab 
cell lines (e.g., HeLa cells). We selected a CEM T-cell line model due to its relevance in immune response, viral 
infection, and cancers, such as T- and B-cell malignancies, for which the HDAC inhibitor drugs, vorinostat and 
romidepsin, are currently being employed for treatment. Since the molecular mechanisms and mode of action for many 
HDAC inhibitors are not fully understood, our study provides new molecular targets and HDAC-associated biological 
functions that can aid in the design of future therapeutic studies. The HDAC1 interactions, B-cell lymphoma/leukemia 
proteins, BCL11A and BCL11B, are responsible for normal lymphoid development and play a role in lymphoid 
malignancies (Liu et al, 2003; Satterwhite et al, 2001). Primarily, it is thought that the BCL11 family plays a role in the 
development of adult T-cell leukemia/lymphoma (ATLL) through their chromosomal amplification and translocation. 
For example, in an adult T-cell leukemia patient the 5’ region of the BCL11B gene was found fused to intron 3 of the 
HELIOS gene (Fujimoto et al, 2012), which interestingly, we also identified as HDAC1 interaction. While the functional 
consequences of these protein-HDAC interactions in the development of ATLL remain to be elucidated, our study fills a 
deficit in knowledge of HDAC interactions in T cells.” 
 
>One minor concern, but still needs addressing is it is not clear why HDAC11 was excluded from the interaction 
network. This section needs to be rewritten with a mathematical, for example, justification given for HDAC11 
exclusion.  
 
We analyzed the HDAC11 interactome separately due to (1) the lack of knowledge regarding HDAC11 biology and 
interactions (less than a dozen citations in Pubmed) and (2) the relatively large number of identified putative 
HDAC11 interactions size. We agree that this aspect was not adequately depicted in the original manuscript. To 
better integrate HDAC11 within the interactome of the other HDACs, we now have included a Supplementary 
Figure S4 to show the common interactions (23 out of 124) between HDAC11 and the interactions from the other 
HDAC1-10. 
 
This point was included in the Results on pg 16: 
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“The enriched functional attributes of HDAC11 interactions are consistent with the limited overlap of the putative 
protein interactions with the other HDACs (Figure S4).”  
  
 
Reviewer #2 (Remarks to the Author):  
 
>In this manuscript, Joshi and collaborators report an interaction network including all human HDACs in T-cells. The 
integrated affinity purification (single GFP immuno-affinity step) and quantitative mass spectrometry to characterize the 
sets of proteins interacting with 11 human HDACs. The experimental strategy is standard and state-of-the-art (AP/MS). 
The data analysis is also based on well established strategies (SAINT and integration of STRING data). The 
experiments are very well controlled and carefully done. This implies an in depth characterization of the baits (EGFP-
fusion) in terms of localization and HDAC activity. The authors could demonstrate that the C-terminally EGFP-tagged 
HDACs are enzymatically active and localize similarly to the wild type versions. The data look solid and imply over 
200 previously unreported HDAC interactions. The authors provide further evidence (co-IP and functional assay) for a 
role of HDAC11 in mRNA splicing. The dataset is likely to be of interest to the scientific community and deserves 
publication.  
 
We appreciate the reviewer’s positive comments and acknowledgment of its significant interest to the scientific 
community. 
 
Several important points though should be addressed:  
 
>1) Adaptation of the SAINT algorithm to the HDAC interactome. The cut-off used, i.e. 0.75, 0,9 and 0.95 depending 
on the HDAC considered (and the numbers of prey found) seems a bit arbitrary. In agreement with this, the authors 
needed to add back manually MEF2C, a well known HDAC interactors that was filtered out by the procedure. Could it 
be that too stringent cut-offs have been applied and other real interactors were filtered out? The authors should produce 
a ROC curve that should easily address the point.  
 
The SAINT cut-offs were selected to adequately balance sensitivity and specificity. We used the iRefIndex database 
of literature curated interactions to guide our selection of SAINT score thresholds. We now provide as a new 
supplemental figure S3, “ROC” curves for representative HDACs (HDAC1, 3, and 4) that had the largest number of 
literature curated interactions. Since (1) database protein interactions are curated across different model system and 
(2) not all HDAC interactions are known (exemplified by our analysis of HDAC1), true positive rates may be 
underestimated, while false positive rates may be overestimated. Therefore, these models should be interpreted 
cautiously. Moreover, since we extended SAINT scoring filters to HDAC interactions that have not been well 
characterized, we selected initial SAINT score thresholds that were more conservative, and were only relaxed upon 
integration with the I-DIRT AP-MS approach. Yet it is important to note that even at these relatively stringent 
thresholds, we identified between 40 – 60% of known interactions in the iRefIndex (Figure S3A-C), which includes 
interactions identified in various cell types and experimental conditions. 
 
We have added the following sentences to the Methods (pg 39) to explain this analysis: 
“Identified bait-prey pairs in the HDAC datasets were cross-referenced with previously cataloged HDAC interactions 
from iRefIndex ver. 10 (Turner et al, 2010). ROC-like curves were constructed for HDAC1, 3, and 4. The iRefIndex 
database was used to plot previously known interactions vs. absent interactions as an approximation for true positive 
and false positive rates, respectively.” 
 
We also include an explanation of this selection of SAINT thresholds in the Results (pg 11):  
“Selection of SAINT scoring thresholds were aided by generating ROC-like curves for HDAC1, 3, and 4, for which the 
greatest number of HDAC interactions have been catalogued. We determined putative protein interactions at different 
SAINT scoring thresholds. Then, by comparison to the iRefIndex database (Turner et al, 2010), we approximated true 
positive and false positive rates based on presence or absence in the iRefIndex database, respectively (see Figure S3).   
Since we do not have reliable estimates of error rates for the lesser studied HDACs, our selection of initial SAINT 
scoring thresholds were conservative. We considered prey proteins with an average score of ≥ 0.75 in at least one 
HDAC isolation as putative specific interactions, except for HDAC1/2 and HDAC11 preys, which required an 
increased stringency of ≥ 0.90 (see Figure S3A) and > 0.95, respectively. Although MEF2C, a well-known interaction 
among the class II HDACs (Lu et al, 2000), was identified in the HDAC immunoisolates, given its lower abundance it 
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did not generate significant spectral counts to pass the SAINT score filters (Table S2) and was therefore manually 
included in subsequent analyses. Yet, even at these relatively stringent thresholds, we identified between 40 – 60% of 
known interactions in the iRefIndex (Figure S3A-C), which includes interactions identified various cell types and 
experimental conditions.” 
 
>2) Phylogenetic relationships among different HDACs (Figures 3). This part is confusing, as the text does not relate to 
what is being shown in Figures 3. The authors say "This is consistent with HDAC1 and HDAC2 comprising a catalytic 
core that functions as part of several multi-protein complexes, including NuRD and CoREST." Is this literature? Then a 
reference should be provided. Is this results? Then this should be shown in figure 3. 
 
The presence of HDAC1 and HDAC2 as a core for several functional complexes has been well established and 
documented by numerous studies.  
As requested, we have included the literature references that support this statement on pg 12: 
“This is consistent with HDAC1 and HDAC2 comprising a catalytic core that functions as part of several multi-protein 
complexes, including NuRD (Tong et al, 1998) and CoREST (You et al, 2001).” 
  
>Similarly, "Three class IIa members, HDAC4, 5, and 7, were part of a single cluster, while HDAC9 had a prey protein 
profile most similar to HDAC8. For this class, clustering was driven by shared interactions with the nuclear co-repressor 
complex (NCoR) (Figure 3, orange) and the 14-3-3 proteins (Figure 3, purple), which facilitate nucleo-cytoplasmic 
shuttling of class IIa HDACs (Grozinger & Schreiber, 2000; Kao et al, 2001; McKinsey et al, 2000b; Yang & Gregoire, 
2005)." This is completely unclear. First HDAC8 and 9 do not (apparently) co-cluster in Figure 3 and second, neither 
NCoR nor 14-3-3 can be seen.  
 
We thank the reviewer for noting the inaccuracy of the second half of the first sentence. Indeed, Figure 3 does not 
clearly support a significant commonality between HDAC9 and HDAC8 interactions.  
The statement on pg 13 has been modified accordingly: "Three class IIa members, HDAC4, 5, and 7, were part of a 
single cluster. For this class, clustering was driven by shared interactions with the nuclear co-repressor complex 
(NCoR)..." 
 
>More worrisome the authors then, a few sentence later, claim that HDAC6, HDAC8 and HDAC9 are "not part of 
larger clusters, each forming their own distinct gene cluster (Figure 3, yellow, teal, and blue)". This is apparently 
contradictory to their statement above.  
Now that the previous comment has been addressed, our assessment of HDAC6, 8, and 9 in Figure 3 is correct and 
consistent with previous statements. 
 
>3) Analysis of the HDAC11 interactome. The figure S2 and the STRING analysis should be clarified, indeed how can 
they find that NUP153 and Dicer1 interact when none of these proteins have been used as bait. I guess this is not 
experimental, but STRING data. Then one wonders what the relevance of this interaction/observation here is. Indeed, 
they (apparently) did not observe the interaction between NUP153 and Dicer, but it was known before. Also in Figure 
S2 (and 5c) HDAC11 cannot be seen, but these proteins are HDAC11 interactors, this needs clarification.  
 
As the reviewer noted, Figure S2 and Fig 5C are functional protein networks assembled by STRING analysis. While 
the network nodes were derived from the HDAC11 candidate interactions, the edges are functional associations 
retrieved from the STRING database.   
 
Towards relevance of this analysis, we chose to perform STRING analysis and overlay experimental enrichment 
indices for several purposes. First, from our previous publication on the interactions of another deacetylase, SIRT7, 
(see ref Tsai et al, MCP; PMID: 22147730) our lab has demonstrated its usefulness in identifying proteins that may 
exist within common/related complexes. Second, HDAC11 is arguably the least well studied HDAC (only ~6 
publications directly to its name, and 9 interactions in the BIOGRID database). Therefore, to gain insight into its 
potential cellular functions, we examined known functional relationships between its candidate interactions.  
 
Since HDAC11 was the only bait protein in the context of our proteomic analysis of HDAC11 interactions, this 
experiment cannot provide direct experimental evidence for any binary relationship, including NUP153-Dicer. For 
this reason, HDAC11 was not integrated into the STRING network as this would suggest a misleading relationship. 
However, this was not our goal for this analysis. Rather, we wanted to identify high value targets for follow-up 
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studies. This is supported by our ultimate finding with targeted experiments that HDAC11 interacts with an SMN 
complex and has a functional effect on mRNA splicing. To better integrate HDAC11 within the interactome of the 
other HDACs, we have now provided a new supplementary figure (Fig. S4) that shows the connectivity of HDAC11 
interactions. 
 
>4) Dynamics of HDAC protein interaction using I-DIRT. It would be interesting to discuss the possible impact of bait-
prey stoichiometries on the apparent exchange of differentially labeled prey. 
 
We agree that the stoichiometry of proteins with HDAC complexes is an important aspect of their regulation. We 
cannot fully address this issue in our current experimental approach that uses relative quantification techniques 
(i.e., I-DIRT/SILAC). However, we did further investigate a similar idea, i.e., the relationship between cellular 
abundance and stability. As shown in new supplementary Figure S7, for HDAC1, we compared the prey protein 
abundances at the proteome level using the PAX database to the relative stability determined by I-DIRT. This 
comparison showed that cellular protein abundance was largely independent of relative I-DIRT stability, suggesting 
that abundance alone may not be a main contributor to stability. However, more detailed studies of stoichiometry 
using alternative quantification techniques would be required to understand this relationship. We feel this is beyond 
the scope of the current study. 
 We have added description of this result on pg. 20. 
“To assess whether relative stability measurements are impacted by overall cellular protein abundances, we compared 
the prey proteome abundance from the PAX database to the relative stability determined by I-DIRT (Figure S7). This 
comparison showed that cellular protein abundance was largely independent of relative I-DIRT stability, suggesting 
that abundance alone may not be a main contributor to stability.”     
 
 
 
 
Reviewer #3 (Remarks to the Author):  
 
Review of "The functional interactome landscape of the human histone deacetylase family."  
 
In this paper, the authors identify the cellular proteins that interact with histone deacetylase (HDAC) proteins in human 
T cells. Interactome datasets were compiled for each of the 11 HDACs via label-free affinity purification followed by 
MS-MS, and then SAINT analysis. Over 200 novel interactions were identified and HDAC-centric interactomes 
revealed HDAC involvement in a variety of processes including ubiquitination and cell cycle regulation. Independent 
analysis of HDAC11 revealed association with RNA editing and processing, specifically with the SMN subnetwork. 
Downregulation of HDAC11 was associated with accumulation of splicing defects in ATXN10 gene. The authors 
complemented their finding with a metabolic labeling approach, I-DIRT, to assess the relative stability of interactions 
and the binding characteristics of each of the HDACs.  
 
This paper is very impactful in that it provides the first comprehensive and global interactome for HDAC proteins. We 
agree with the authors that this is particularly important given that HDACs are the targets of several drugs in clinical 
trials, but the ability to assess their global effect is impaired due to lack of knowledge about the biological pathways and 
systems in which HDACs are involved. Additionally, the authors have developed a hybrid proteomic approach that can 
be adapted to the study of other protein interaction networks. By using numerous examples from the literature, they 
show that the complementarity of the two approaches raises the confidence level of the interactions identified. Overall 
the paper is well researched, contains a high degree of novelty and is a useful resource platform for further 
investigations into the HDAC protein family.  
 
Major comments  
>The authors should find a way to validate the I-DIRT method. They show binding by two proteins by IP and by 
colocalization, but they do not show a way to validate their binding strength. This can be done, for example, by salt 
extraction. 
  
We agree with the reviewer that the use of the integrated I-DIRT/SAINT approach for determining relative 
interaction stability is very valuable and can be utilized when studying diverse complexes, and that these findings 
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could be strengthened by additional experiments. To validate our I-DIRT observations, we have designed and 
successfully performed two experiments: 
1. We performed a biochemical validation of HDAC1 interaction stability. We isolated HDAC1-EGFP using 
lysis buffer conditions with increasing salt concentrations. To determine the relative resistance of the 
interactions to the increased salt concentrations, we analyzed the co-isolated proteins by mass spectrometry. 
Stable interactions, such as the NuRD complex, remained largely associated with HDAC1 at high salt 
concentration. In contrast, the interactions with transcription factors and zinc finger proteins were depleted 
in a dose-dependent manner. A clear validation of our I-DIRT results is given by the striking difference 
between the trends of the zinc finger proteins. The known CtBP complex components, ZNF516 and 
ZNF217, were stable at high salt concentrations, while the previously uncharacterized zinc finger proteins 
that I-DIRT predicted as less stable interactions were depleted in a KCl-dependent manner. We illustrate 
these results in the new Figure 7A.  
2. Similarly, we performed additional validation of HDAC7 interaction stability with TBL1XR1 and HDAC3. 
I-DIRT predicted these interactions as less stable, in agreement with the nuclear-cytoplasmic shuttling of 
HDAC7. Upon isolation of HDAC7-EGFP under lysis buffer conditions with increasing KCl 
concentrations, we demonstrate by Western blotting that these HDAC7 interactions are diminished in a 
dose-dependent manner. We illustrate these results in the new Figure 7B. 
 
We have included these new Results on pg 21-22: 
“To biochemically validate the ability of the I-DIRT/SAINT approach to determine relative interaction stability, we 
independently isolated HDAC1-EGFP using lysis buffer conditions with increasing KCl concentrations. We 
assessed the relative abundance of co-isolated interactions by mass spectrometry. As predicted, stable interactions, 
such as the NuRD complex, remained largely associated with HDAC1 at high salt concentration (Figure 7A). In 
contrast, the interactions with transcription factors and zinc finger proteins were depleted in a dose-dependent 
manner. A clear validation of our I-DIRT results is shown by the striking difference between the relative stability 
trends of zinc finger proteins. The known CtBP complex components, ZNF516 and ZNF217, were stable at high 
salt concentrations, while the previously uncharacterized zinc finger proteins that I-DIRT predicted as less stable 
interactions (Figure 6E-F) were depleted in a KCl-dependent manner (Figure 7A). Similarly, we performed 
validation of HDAC7 interaction stability with TBL1XR1 and HDAC3 (Figure 7B). I-DIRT predicted these 
interactions as less stable (Figure 6B), in agreement with the nuclear-cytoplasmic shuttling of HDAC7. Upon 
isolation of HDAC7-EGFP under lysis buffer conditions with increasing KCl concentrations, we observed by 
Western blotting that TBL1XR1 and HDAC3 are diminished in a dose-dependent manner. Altogether, these results 
support the use of the integrated I-DIRT/SAINT approach for profiling relative protein interaction stabilities.” 
 
>In the HDAC11 analysis only one intron of the ATXN10 gene is shown to be misspliced while the wording of the 
relevant section claims that SMN1 deletion purturbs the splicing of more than one U12 intron (Boulisfane et al, 2011). 
Did the authors check any of the other introns? If there wasn't intron retention, was there a difference in splicing 
efficiency? Can the authors check some other genes with U12 introns to show that this is a general phenomenon?  
 
We took the reviewer’s suggestion and have now clarified the impact of HDAC11 on splicing. Analysis of the U12 
intron database (http://genome.crg.es/cgi-bin/u12db/u12db.cgi) lists that the ATXN10 gene has only one U12-intron 
(I10), which was previously demonstrated to be mis-spliced in SMN1-/- lymphoblasts (Boulisfane et al., 2011; PMID 
21098506). In our experiments, we tested the same intron and demonstrated that there is retention of the I10 intron, 
but no apparent defect in splicing efficiency (Figure 5E). To determine if this is a broader phenomenon, we 
performed additional experiments and tested if the U12 intron from Thoc2 (I37) (Boulisfane et al., 2011) was also 
mis-spliced. Our results show that there are no retention events and there was no difference in splicing efficiency for 
the Thoc2 gene. 
Noteworthy, Boulisfane et al. 2011, report that SMN1-/- lymphoblasts show intron retention defects in only three 
genes (out of 30 tested), suggesting that this may not be a general phenomenon and could be tissue type specific. This 
is supported by the report from Zhang et al., 2008, where an examination of alternate splicing changes in the 
genome reveals that a different set of genes showed splicing changes in the three tissue types tested: brain, kidney 
and spinal cord.  
In summary, our HDAC11 interaction analysis and validation studies provide proof that HDAC11 serves as a part of 
the SMN1 complex, and establish its role in splicing of the ATXN10 gene. Our results suggest that HDAC11 has a 
more subtle effect on intron retention than SMN1 deficiency, which may indicate a possible indirect role via the 
SMN complex or a more specialized role in ATXN10 gene processing. A complete elucidation of these functions 
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would require many additional studies that are outside the scope of this current manuscript. We have added these 
new results and the relevant discussion to the new manuscript (pg. 17 and 31).  
Pg. 17 - “Homozygous deletion of SMN1 was shown to be accompanied by intron retention in the U12-type intron from 
the ATXN10 and Thoc2 genes in lymphoblasts derived from patients with spinal muscular atrophy (Boulisfane et al, 
2011). We therefore tested the hypothesis that HDAC11 down-regulation would lead to similar splicing defects through 
disruption of spliceosome function. Upon knockdown of HDAC11 in wild-type CEM-T cells, using qRT-PCR we 
observed an accumulation of mis-spliced ATXN10 mRNA, which was not detected in the non-targeted siRNA control 
(Figure 5E). A similar analysis of Thoc2 indicated that there was no splicing defect in the I37 intron from this gene 
(Figure S6B).” 
Pg. 31 - “We demonstrate that HDAC11 downregulation triggers a similar splicing defect of the U12-type intron (I10) 
from the ATXN10 gene. In contrast, no retention events and no difference in splicing efficiency were observed for the 
Thoc2 gene, suggesting that HDAC11 has a more subtle effect on intron retention than SMN1 deficiency. HDAC11 may 
have an indirect role via the SMN complex or a more specialized role in ATXN10 gene processing. These results 
establish a previously unreported function for HDAC11 in splicing, suggesting a role in the assembly or stabilization of 
the SMN complex.” 
 
Minor comments:  
>In section "Protein interaction clustering reflect phylogenetic relationships and functional commonalities among 
distinct HDACs": The authors write "HDAC bait spectral counts were removed to prevent clustering bias", but the 
heatmap figure contains HDAC proteins and spectral counts even in the vector representing the experiment in which 
they should be the bait (e.g. HDAC1 has a yellow color in columns one and two representing the HDAC 1-1 and 
HDAC1-2 affinity assays). This should be clarified.  
 
In columns 1 and 2, it is HDAC2 that has an intense yellow signal. This is expected as we did not remove spectral 
counts for HDACs that were found in a different HDAC isolation. 
 
>Can the authors explain why the interactome and heatmap don't contain histone proteins? The interaction table in the 
Excel file contains histone proteins for several of the HDACs but they are not shown in the heatmap. 
 
The Excel file, Table S2, which lists the SAINT-specific interactions, contains a single histone, histone H1x, which 
appears in the heatmap and network. The remaining histones listed in Table S3, did not pass the SAINT specificity 
criteria as the background level of captured histones was relatively high in the EGFP alone isolations. The 
observation that some abundant and “promiscuous” proteins exhibit non-specific behavior under control conditions 
is one unfortunate drawback of immunoisolation techniques.  
  
>"Clustering of biological replicates showed highest similarity to each other" - this is not so for HDAC5-1, HDAC5-2, 
or HDAC4-3. This sentence should be less absolute. Also, why do some HDACs have three biorepeats? Should be 
clarified.  
 
We have now changed the sentence to, “clustering of biological replicates showed a high degree of similarly to each 
other” on pg 12. Regarding the additional replicates, these particular HDACs are of great interest for several 
projects in our lab, and additional independent immunoisolations had been performed by several different lab 
members, but under identical conditions. Therefore, we decided to include these additional replicates. 
 
>In wording referring to Figure 6, the gene HBP1 (Swanson et al, 2004) is mentioned, but it is not in the figure. 
 
We have labeled the data point corresponding to the relative specificity/stability of HBP1 in Figure 6D and 
referenced this figure panel in the manuscript on pg 22. 
 
 
 
>The reference to Figure S4 should be S3. 
 
Thank you. This has been corrected, and updated to the new numbering, therefore, new Figure S8. 
 
>In Figure 5B, the meaning of the clump of green circles at the bottom is unclear. 
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We have further clarified this in the figure legend on pg 46, and have included a new supplementary figure showing 
the complete annotation of the green circles (new Figure S6).  
“For clarity, a subset of GO BP term labels relating to detailed RNA metabolic processes were removed (see Figure 
S6A).” 
 
 
>In Figure 6C,D the Y axis is named differently. In C it's "SAINT score" and in D it's "SAINT probability". For D, the 
graph is unnecessary since it contains no points. It's enough to have the color bar with a number legend for the I-DIRT 
stability ratio and then the chart on the right of the HDACs vs. other proteins.  
 
We have corrected in panel D, SAINT probability to “score” for consistency within the text and other figure panels.   
 
Though we have considered the reviewer’s suggestion for modification of panel D, we ultimately felt that the 
inclusion of the graph axes unambiguously illustrates an important point, namely that only proteins passing SAINT 
specificity thresholds were considered for stability profiling. Therefore we have elected to retain the original version 
of the figure for an increased clarity for a broad audience.  
 
>Figure 2A - where does the metabolic -labeled affinity purification come in to play? The box says LC-MS/MS 
Analysis...  
 
Both label-free and metabolic-labeled purifications were subjected to peptide analysis by LC-MS/MS, so this step is 
the same. The most significant differences in the overall workflow were (1) the mixing of heavy-labeled WT cells 
preceding the affinity purification, as shown in the workflow and Methods section, and (2) isotope-based 
quantification of peptides, as shown by the I-DIRT graphic of a light peptide and light/heavy peptide pair.  
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